All In Biotech

Drug Trial Radar · NCT07210515

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

A Randomized, Triple-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Intravenous AMBTX-01 (Neridronate) for Treatment of Complex Regional Pain Syndrome Type 1 (CRPS-RISE)

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 270 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

270

Planned (sponsor's estimate)

Start

Apr 14, 2026

Primary completion

Dec 2027

Study completion Jan 2028

Sponsor

Lead sponsor
Ambros Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Oct 7, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1

Conditions

  • Complex Regional Pain Syndrome Type I

Interventions

  • NeridronateDrug

    neridronate 100 mg, given as a 2-hour infusion on Days 1, 4, 7, and 10.

  • PlaceboDrug

    placebo comparator

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in pain intensity from baseline to Week 12.Time frame: Week 12

Locations

36 sites in 1 country. Site status is shown where the registry gives one.

  • Ambros Clinical Trial Site

    Phoenix, Arizona · Recruiting

  • Ambros Clinical Trial Site

    Tucson, Arizona · Recruiting

  • Ambros Clinical Trial Site

    Little Rock, Arkansas · Recruiting

  • Ambros Clinical Trial Site

    La Jolla, California · Recruiting

  • Ambros Clinical Trial Site

    Napa, California · Recruiting

  • Ambros Clinical Trial Site

    Pasadena, California · Recruiting

  • Ambros Clinical Trial Site

    Santa Monica, California · Recruiting

  • Ambros Clinical Trial Site

    Tustin, California · Recruiting

  • Ambros Clinical Trial Site

    Washington D.C., District of Columbia · Recruiting

  • Ambros Clinical Trial Site

    Brandon, Florida · Recruiting

  • Ambros Clinical Trial Site

    Daytona Beach, Florida · Recruiting

  • Ambros Clinical Trial Site

    Pembroke Pines, Florida · Recruiting

  • Ambros Clinical Trial Site

    Lawrenceville, Georgia · Recruiting

  • Ambros Clinical Trial Site

    Newnan, Georgia · Recruiting

  • Ambros Clinical Trial Site

    Chicago, Illinois · Recruiting

  • Ambros Clinical Trial Site

    Orland Park, Illinois · Recruiting

  • Ambros Clinical Trial Site

    Overland Park, Kansas · Recruiting

  • Ambros Clinical Trial Site

    Dearborn, Michigan · Recruiting

  • Ambros Clinical Trial Site

    Creve Coeur, Missouri · Recruiting

  • Ambros Clinical Trial Site

    Reno, Nevada · Recruiting

  • Ambros Clinical Trial Site

    Shrewsbury, New Jersey · Recruiting

  • Ambros Clinical Trial Site

    Smithtown, New York · Recruiting

  • Ambros Clinical Trial Site

    Charlotte, North Carolina · Recruiting

  • Ambros Clinical Trial Site

    Wilmington, North Carolina · Recruiting

  • Ambros Clinical Trial Site

    Winston-Salem, North Carolina · Recruiting

  • Ambros Clinical Trial Site

    Cleveland, Ohio · Recruiting

  • Ambros Clinical Trial Site

    Dayton, Ohio · Recruiting

  • Ambros Clinical Trial Site

    Fort Worth, Texas · Recruiting

  • Ambros Clinical Trial Site

    Houston, Texas · Recruiting

  • Ambros Clinical Trial Site

    Lubbock, Texas · Recruiting

  • Ambros Clinical Trial Site

    Mesquite, Texas · Recruiting

  • Ambros Clinical Trial Site

    Mesquite, Texas · Recruiting

  • Ambros Clinical Trial Site

    San Antonio, Texas · Recruiting

  • Ambros Clinical Trial Site

    Charlottesville, Virginia · Recruiting

  • Ambros Clinical Trial Site

    Richmond, Virginia · Recruiting

  • Ambros Clinical Trial Site

    Seattle, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.